Causal integration of multi‐omics data with prior knowledge to generate mechanistic hypotheses
Open accessPublished version of a preprint
The DOI matches its Crossref record; 88 of the 89 references it cites were found in a registry or an index.
Abstract
Multi‐omics datasets can provide molecular insights beyond the sum of individual omics. Various tools have been recently developed to integrate such datasets, but there are limited strategies to systematically extract mechanistic hypotheses from them. Here, we present COSMOS (Causal Oriented Search of Multi‐Omics Space), a method that integrates phosphoproteomics, transcriptomics, and metabolomics datasets. COSMOS combines extensive prior knowledge of signaling, metabolic, and gene regulatory networks with computational methods to estimate activities of transcription factors and kinases as well as network‐level causal reasoning. COSMOS provides mechanistic hypotheses for experimental observations across multi‐omics datasets. We applied COSMOS to a dataset comprising transcriptomics, phosphoproteomics, and metabolomics data from healthy and cancerous tissue from eleven clear cell renal cell carcinoma (ccRCC) patients. COSMOS was able to capture relevant crosstalks within and between multiple omics layers, such as known ccRCC drug targets. We expect that our freely available method will be broadly useful to extract mechanistic insights from multi‐omics studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“COSMOS is a recently published method to integrate multi-omics data and prior knowledge to extract active sub-networks in a given functional context via causal reasoning (Dugourd et al, 2021).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Dugourd et al, 2021
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Samanta, D., Gilkes, D. M., Chaturvedi, P., Xiang, L., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421438111 · Cited by 460
RetractedZhou, W., Wu, G., Huang, J., Li, J., Hao, C., He, Q., Chen, X.-D., Wang, G., & Tu, X. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.11.016 · Cited by 32
RetractedR: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Subramanian, A., Narayan, R., Corsello, S. M., Peck, D. D., Natoli, T. E., Lu, X., Gould, J., Davis, J. F., Tubelli, A. A., Asiedu, J. K., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.049 · Cited by 3,515
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485
A pathology atlas of the human cancer transcriptome
Uhlen, M., Zhang, C., Lee, S., Sjöstedt, E., Fagerberg, L., Bidkhori, G., Benfeitas, R., Arif, M., Liu, Z., Edfors, F., et al. (2017) · Science · doi:10.1126/science.aan2507 · Cited by 3,371
Huber, W., von Heydebreck, A., Sültmann, H., Poustka, A., & Vingron, M. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.suppl_1.s96 · Cited by 2,440
A Landscape of Pharmacogenomic Interactions in Cancer
Iorio, F., Knijnenburg, T. A., Vis, D. J., Bignell, G. R., Menden, M. P., Schubert, M., Aben, N., Gonçalves, E., Barthorpe, S., Lightfoot, H., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.017 · Cited by 2,090 · cited 1×
“Beads were washed with five different buffers: (1) 80% ACN and 6% TFA, (2) 10% ACN and 6% TFA, (3) 80% ACN and 1% TFA, (4) 50% ACN and 1% TFA, (5) 10% ACN and 1% TFA.”
HIF-1α pathway: role, regulation and intervention for cancer therapy
Masoud, G. N., & Li, W. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.05.007 · Cited by 1,871
STITCH 5: augmenting protein–chemical interaction networks with tissue and affinity data
Szklarczyk, D., Santos, A., von Mering, C., Jensen, L. J., Bork, P., & Kuhn, M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1277 · Cited by 1,687
Multi-Omics Factor Analysis—a framework for unsupervised integration of multi-omics data sets
Argelaguet, R., Velten, B., Arnol, D., Dietrich, S., Zenz, T., Marioni, J. C., Buettner, F., Huber, W., & Stegle, O. (2018) · Molecular Systems Biology · doi:10.15252/msb.20178124 · Cited by 1,510
Benchmark and integration of resources for the estimation of human transcription factor activities
Garcia-Alonso, L., Holland, C. H., Ibrahim, M. M., Turei, D., & Saez-Rodriguez, J. (2019) · Genome Research · doi:10.1101/gr.240663.118 · Cited by 1,122
Perturbation-response genes reveal signaling footprints in cancer gene expression
(2017) · doi:10.1038/s41467-017-02391-6 · Cited by 1,108
DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays
Singh, A., Shannon, C. P., Gautier, B., Rohart, F., Vacher, M., Tebbutt, S. J., & Lê Cao, K.-A. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty1054 · Cited by 1,072
Alvarez, M. J., Shen, Y., Giorgi, F. M., Lachmann, A., Ding, B. B., Ye, B. H., & Califano, A. (2016) · Nature Genetics · doi:10.1038/ng.3593 · Cited by 966
Recon3D enables a three-dimensional view of gene variation in human metabolism
Brunk, E., Sahoo, S., Zielinski, D. C., Altunkaya, A., Dräger, A., Mih, N., Gatto, F., Nilsson, A., Preciat Gonzalez, G. A., Aurich, M. K., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4072 · Cited by 752
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
Clark, D. J., Dhanasekaran, S. M., Petralia, F., Pan, J., Song, X., Hu, Y., da Veiga Leprevost, F., Reva, B., Lih, T.-S. M., Chang, H.-Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.007 · Cited by 730
OmniPath: guidelines and gateway for literature-curated signaling pathway resources
Türei, D., Korcsmáros, T., & Saez-Rodriguez, J. (2016) · Nature Methods · doi:10.1038/nmeth.4077 · Cited by 687
Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition
Sciacovelli, M., Gonçalves, E., Johnson, T. I., Zecchini, V. R., da Costa, A. S. H., Gaude, E., Drubbel, A. V., Theobald, S. J., Abbo, S. R., Tran, M. G. B., et al. (2016) · Nature · doi:10.1038/nature19353 · Cited by 584
Self-citationHIF-α effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma
Gordan, J. D., Lal, P., Dondeti, V. R., Letrero, R., Parekh, K. N., Oquendo, C. E., Greenberg, R. A., Flaherty, K. T., Rathmell, W. K., Keith, B., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.016 · Cited by 493
MOLI: multi-omics late integration with deep neural networks for drug response prediction
Sharifi-Noghabi, H., Zolotareva, O., Collins, C. C., & Ester, M. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz318 · Cited by 421
Casado, P., Rodriguez-Prados, J.-C., Cosulich, S. C., Guichard, S., Vanhaesebroeck, B., Joel, S., & Cutillas, P. R. (2013) · Science Signaling · doi:10.1126/scisignal.2003573 · Cited by 409
Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer
Schödel, J., Grampp, S., Maher, E. R., Moch, H., Ratcliffe, P. J., Russo, P., & Mole, D. R. (2016) · European Urology · doi:10.1016/j.eururo.2015.08.007 · Cited by 405
Regulation of cancer cell metabolism: Oncogenic MYC in the driver’s seat
Dong, Y., Tu, R., Liu, H., & Qing, G. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00235-2 · Cited by 405
Aurora kinases: novel therapy targets in cancers
Tang, A., Gao, K., Chu, L., Zhang, R., Yang, J., & Zheng, J. (2017) · Oncotarget · doi:10.18632/oncotarget.14893 · Cited by 382
A systematic evaluation of normalization methods in quantitative label-free proteomics
Välikangas, T., Suomi, T., & Elo, L. L. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw095 · Cited by 336
Holland, C. H., Tanevski, J., Perales-Patón, J., Gleixner, J., Kumar, M. P., Mereu, E., Joughin, B. A., Stegle, O., Lauffenburger, D. A., Heyn, H., et al. (2020) · Genome Biology · doi:10.1186/s13059-020-1949-z · Cited by 323
The KSEA App: a web-based tool for kinase activity inference from quantitative phosphoproteomics
Wiredja, D. D., Koyutürk, M., & Chance, M. R. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx415 · Cited by 322
Regulation of c-myc expression by IFN-γ through Stat1-dependent and -independent pathways
Ramana, C. V., Grammatikakis, N., Chernov, M., Nguyen, H., Chuan Goh, K., Williams, B. R. G., & Stark, G. R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.2.263 · Cited by 319
Branched-chain amino acid metabolism in cancer
Ananieva, E. A., & Wilkinson, A. C. (2018) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000430 · Cited by 291
Shroff, E. H., Eberlin, L. S., Dang, V. M., Gouw, A. M., Gabay, M., Adam, S. J., Bellovin, D. I., Tran, P. T., Philbrick, W. M., Garcia-Ocana, A., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507228112 · Cited by 255
Variable selection for generalized canonical correlation analysis
Tenenhaus, A., Philippe, C., Guillemot, V., Le Cao, K.-A., Grill, J., & Frouin, V. (2014) · Biostatistics · doi:10.1093/biostatistics/kxu001 · Cited by 234
Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer
Drake, J. M., Paull, E. O., Graham, N. A., Lee, J. K., Smith, B. A., Titz, B., Stoyanova, T., Faltermeier, C. M., Uzunangelov, V., Carlin, D. E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.07.007 · Cited by 224
Wang, K., Sun, Y., Tao, W., Fei, X., & Chang, C. (2017) · Cancer Letters · doi:10.1016/j.canlet.2016.12.036 · Cited by 221
Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer
Vanharanta, S., Shu, W., Brenet, F., Hakimi, A. A., Heguy, A., Viale, A., Reuter, V. E., Hsieh, J. J.-D., Scandura, J. M., & Massagué, J. (2013) · Nature Medicine · doi:10.1038/nm.3029 · Cited by 215
Paull, E. O., Carlin, D. E., Niepel, M., Sorger, P. K., Haussler, D., & Stuart, J. M. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt471 · Cited by 209
VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma
Zhang, J., Wu, T., Simon, J., Takada, M., Saito, R., Fan, C., Liu, X.-D., Jonasch, E., Xie, L., Chen, X., et al. (2018) · Science · doi:10.1126/science.aap8411 · Cited by 203
Transcription Factor Activities Enhance Markers of Drug Sensitivity in Cancer
Garcia-Alonso, L., Iorio, F., Matchan, A., Fonseca, N., Jaaks, P., Peat, G., Pignatelli, M., Falcone, F., Benes, C. H., Dunham, I., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1679 · Cited by 202
Critical protein GAPDH and its regulatory mechanisms in cancer cells.
Zhang, J., Zhang, F., Hong, C., Giuliano, A. E., Cui, X., Zhou, G.-J., Zhang, G., & Cui, Y. (2015) · PubMed · doi:10.7497/j.issn.2095-3941.2014.0019 · Cited by 197
Analysis of Cell Metabolism Using LC-MS and Isotope Tracers
Mackay, G. M., Zheng, L., van den Broek, N. J. F., & Gottlieb, E. (2015) · Methods in Enzymology · doi:10.1016/bs.mie.2015.05.016 · Cited by 197
Mining for regulatory programs in the cancer transcriptome
Rhodes, D. R., Kalyana-Sundaram, S., Mahavisno, V., Barrette, T. R., Ghosh, D., & Chinnaiyan, A. M. (2005) · Nature Genetics · doi:10.1038/ng1578 · Cited by 169
Overexpression of hypoxia-inducible factor and metabolic pathways: possible targets of cancer
Singh, D., Arora, R., Kaur, P., Singh, B., Mannan, R., & Arora, S. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0190-2 · Cited by 166
Liu, A., Trairatphisan, P., Gjerga, E., Didangelos, A., Barratt, J., & Saez-Rodriguez, J. (2019) · npj Systems Biology and Applications · doi:10.1038/s41540-019-0118-z · Cited by 151
Self-citationAURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy
Bertran-Alamillo, J., Cattan, V., Schoumacher, M., Codony-Servat, J., Giménez-Capitán, A., Cantero, F., Burbridge, M., Rodríguez, S., Teixidó, C., Roman, R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09734-5 · Cited by 138
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
Clark, D. J., Dhanasekaran, S. M., Petralia, F., Pan, J., Song, X., Hu, Y., Leprevost, F. D. V., Reva, B. A., Lih, T. M., Chang, H.-Y., et al. (2020) · Cell · doi:10.1016/j.cell.2019.12.026 · Cited by 120
HNF4α reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma
Lucas, B., Grigo, K. N. C., Erdmann, S., Lausen, J., Klein‐Hitpaß, L., & Ryffel, G. U. (2005) · Oncogene · doi:10.1038/sj.onc.1208794 · Cited by 109
An atlas of human kinase regulation
Ochoa, D., Jonikas, M., Lawrence, R. T., El Debs, B., Selkrig, J., Typas, A., Villén, J., Santos, S. D., & Beltrao, P. (2016) · Molecular Systems Biology · doi:10.15252/msb.20167295 · Cited by 102
Ranking metrics in gene set enrichment analysis: do they matter?
Żyła, J., Marczyk, M., Weiner, J. M., & Polańska, J. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1674-0 · Cited by 101
Flux balance analysis predicts essential genes in clear cell renal cell carcinoma metabolism
Gatto, F., Miess, H., Schulze, A., & Nielsen, J. (2015) · Scientific Reports · doi:10.1038/srep10738 · Cited by 100
Wnt Signaling in Renal Cell Carcinoma
Xu, Q., Krause, M., Samoylenko, A., & Vainio, S. (2016) · Cancers · doi:10.3390/cancers8060057 · Cited by 99
MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma
Bailey, S. T., Smith, A. M., Kardos, J., Wobker, S. E., Wilson, H. L., Krishnan, B., Saito, R., Lee, H. J., Zhang, J., Eaton, S. C., et al. (2017) · Nature Communications · doi:10.1038/ncomms15770 · Cited by 95
STAT1 Drives Tumor Progression in Serous Papillary Endometrial Cancer
Kharma, B., Baba, T., Matsumura, N., Kang, H. S., Hamanishi, J., Murakami, R., McConechy, M. M., Leung, S., Yamaguchi, K., Hosoe, Y., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0847 · Cited by 88
Austen, M., Cerni, C., Lüscher‐Firzlaff, J., & Lüscher, B. (1998) · Oncogene · doi:10.1038/sj.onc.1201968 · Cited by 81
Tumor Necrosis Factor Receptor Expression and Signaling in Renal Cell Carcinoma
Al‐Lamki, R. S., Sadler, T. J., Wang, J., Reid, M. J., Warren, A. Y., Movassagh, M., Lu, W., Mills, I. G., Neal, D. E., Burge, J., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091218 · Cited by 77
Network-based metabolic characterization of renal cell carcinoma
Pandey, N., Lanke, V., & Vinod, P. K. U. (2020) · Scientific Reports · doi:10.1038/s41598-020-62853-8 · Cited by 75
Classification of gene signatures for their information value and functional redundancy
Cantini, L., Calzone, L., Martignetti, L., Rydenfelt, M., Blüthgen, N., Barillot, E., & Zinovyev, A. Y. (2017) · npj Systems Biology and Applications · doi:10.1038/s41540-017-0038-8 · Cited by 68
The Expression and Evaluation of Androgen Receptor in Human Renal Cell Carcinoma
Zhu, G., Liang, L., Li, L., Dang, Q., Song, W., Yeh, S., He, D., & Chang, C. (2013) · Urology · doi:10.1016/j.urology.2013.10.022 · Cited by 67
Targeting PDK1 for Chemosensitization of Cancer Cells
Emmanouilidi, A., & Falasca, M. (2017) · Cancers · doi:10.3390/cancers9100140 · Cited by 66
YES1 Is a Targetable Oncogene in Cancers Harboring YES1 Gene Amplification
Hamanaka, N., Nakanishi, Y., Mizuno, T., Horiguchi-Takei, K., Akiyama, N., Tanimura, H., Hasegawa, M., Satoh, Y., Tachibana, Y., Fujii, T., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3376 · Cited by 65
Engers, R., Mrzyk, S., Springer, E., Fabbro, D., Weissgerber, G., Gerharz, C., & Gabbert, H. E. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1043 · Cited by 60
NF-κB–Dependent Lymphoid Enhancer Co-option Promotes Renal Carcinoma Metastasis
Rodrigues, P., Patel, S. A., Harewood, L., Olan, I., Vojtasova, E., Syafruddin, S. E., Zaini, M. N., Richardson, E. K., Burge, J., Warren, A. Y., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1211 · Cited by 59
Meta-Analysis Identifies NF-κB as a Therapeutic Target in Renal Cancer
Peri, S., Devarajan, K., Yang, D., Knudson, A. G., & Balachandran, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076746 · Cited by 56
Footprint-based functional analysis of multiomic data
Dugourd, A., & Saez-Rodriguez, J. (2019) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2019.04.002 · Cited by 53
Self-citationRichard, C. L., Tan, E. Y., & Blay, J. (2006) · International Journal of Cancer · doi:10.1002/ijc.22084 · Cited by 52
AURKB : a promising biomarker in clear cell renal cell carcinoma
Wan, B., Huang, Y., Liu, B., Lu, L., & Lv, C. (2019) · PeerJ · doi:10.7717/peerj.7718 · Cited by 51
Melas, I. N., Sakellaropoulos, T., Iorio, F., Alexopoulos, L. G., Loh, W., Lauffenburger, D. A., Sáez-Rodríguez, J., & Bai, J. P. F. (2015) · Integrative Biology · doi:10.1039/c4ib00294f · Cited by 50
An, J., & Rettig, M. B. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0255 · Cited by 50
Role of carnitine in cancer chemotherapy-induced multiple organ toxicity
Sayed‐Ahmed, M. M. (2010) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2010.07.008 · Cited by 50
Protein kinase C eta is associated with progression of renal cell carcinoma (RCC).
Brenner, W., Färber, G., Herget, T., Wiesner, C., Hengstler, J. G., & Thüroff, J. W. (2003) · PubMed · Cited by 50
NF-κB1 inhibits c-Myc protein degradation through suppression of FBW7 expression
Huang, H., Ma, L., Li, J., Yu, Y., Zhang, D., Wei, J., Jin, H., Xu, D. C., Gao, J., & Huang, C. (2014) · Oncotarget · doi:10.18632/oncotarget.1643 · Cited by 49
Rolland-Turner, M., Goretti, E., Bousquenaud, M., Léonard, F., Nicolas, C., Zhang, L., Maskali, F., Marie, P., Devaux, Y., & Wagner, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054135 · Cited by 48
A Protective Role for Androgen Receptor in Clear Cell Renal Cell Carcinoma Based on Mining TCGA Data
Zhao, H., Leppert, J. T., & Peehl, D. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146505 · Cited by 47
Exploiting Interdata Relationships in Next-generation Proteomics Analysis
Vitrinel, B., Koh, H. W. L., Kar, F. M., Maity, S., Rendleman, J., Choi, H., & Vogel, C. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.mr118.001246 · Cited by 46
Kawata, K., Hatano, A., Yugi, K., Kubota, H., Sano, T., Fujii, M., Tomizawa, Y., Kokaji, T., Tanaka, K. Y., Uda, S., et al. (2018) · iScience · doi:10.1016/j.isci.2018.07.022 · Cited by 41 · cited 2×
“Protease activity was quenched by acidification with TFA, and the resulting peptide mixture was concentrated on C18 Sep Pak Cartridges (Waters).”
Popławski, P., Tohge, T., Bogusławska, J., Rybicka, B., Tański, Z., Treviño, V., Fernie, A. R., & Piekiełko‐Witkowska, A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.12.011 · Cited by 28
Thapa, R. J., Chen, P., Cheung, M., Nogusa, S., Pei, J., Peri, S., Testa, J. R., & Balachandran, S. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1010 · Cited by 22
The landscape of tiered regulation of breast cancer cell metabolism
Katzir, R., Polat, I. H., Harel, M., Katz, S., Foguet, C., Selivanov, V. A., Sabatier, P., Cascante, M., Geiger, T., & Ruppin, E. (2019) · Scientific Reports · doi:10.1038/s41598-019-54221-y · Cited by 22
Kearney, A. Y., Fan, Y.-H., Giri, U. P., Saigal, B., Gandhi, V. V., Heymach, J. V., & Zurita, A. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135962 · Cited by 20
A study exploring critical pathways in clear cell renal cell carcinoma
Zeng, Z., Que, T., Zhang, J., & Hu, Y. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1392 · Cited by 19
Liu, A., Trairatphisan, P., Gjerga, E., Didangelos, A., Barratt, J., & Sáez-Rodríguez, J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/541888 · Cited by 19
Self-citationYan, L., Zhang, Y., Ding, B., Zhou, H., Yao, W., & Xu, H. (2019) · PeerJ · doi:10.7717/peerj.6396 · Cited by 18
Liu, W., Payne, S., Ma, S., & Fenyö, D. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir119.001442 · Cited by 17
Jelinek, D. F., & Wu, X. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.14264142.15777309 · Cited by 1
Cited by
Metabolomics in cancer research and emerging applications in clinical oncology
Schmidt, D. R., Patel, R., Kirsch, D. G., Lewis, C. A., Vander Heiden, M. G., & Locasale, J. W. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21670 · Cited by 648
Machine Learning Applications for Mass Spectrometry-Based Metabolomics
Liebal, U. W., Phan, A. N. T., Sudhakar, M., Raman, K., & Blank, L. M. (2020) · Metabolites · doi:10.3390/metabo10060243 · Cited by 357
LIANA+ Provides an All-in-One Framework for Cell–Cell Communication Inference
Dimitrov, D., Schäfer, P. S. L., Farr, E., Rodriguez-Mier, P., Lobentanzer, S., Badia-i-Mompel, P., Dugourd, A., Tanevski, J., Ramirez Flores, R. O., & Saez-Rodriguez, J. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01469-w · Cited by 263
“We applied this method to link deregulated protein-mediated CCC and TFs, but it should be applicable to any set of molecules, including metabolite-mediated signalling networks 60 .”
Self-citationA guide to multi-omics data collection and integration for translational medicine
Athieniti, E., & Spyrou, G. M. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.11.050 · Cited by 174
“COSMOS [73] uses a meta prior knowledge network (metaPKN) produced from databases STITCH, OmniPath and Recon3D.”
De Domenico, M., Allegri, L., Caldarelli, G., d’Andrea, V., Di Camillo, B., Rocha, L. M., Rozum, J., Sbarbati, R., & Zambelli, F. (2025) · npj Digital Medicine · doi:10.1038/s41746-024-01402-3 · Cited by 159
Metadata
- Authors
- Dugourd, A., Kuppe, C., Sciacovelli, M., Gjerga, E., Gabor, A., Emdal, K. B., Vieira, V., Bekker‐Jensen, D. B., Kranz, J., Bindels, E. M. J., Costa, A. S. H., Sousa, A., Beltrao, P., Rocha, M., Olsen, J. V., Frezza, C., Kramann, R., & Saez‐Rodriguez, J.
- Affiliations
- Erasmus MC (NL)
- University of Cambridge (GB)
- Heidelberg University (DE)
- University of Copenhagen (DK)
- Sankt-Antonius-Hospital Eschweiler (DE)
- European Bioinformatics Institute (GB)
- University of Minho (PT)
- Corresponding author
- Frezza, Christian
- Kramann, Rafael
- ORCID
- Venue
- Molecular Systems Biology
- Published
- 2021-01-01
- Volume
- 17
- Issue
- 1
- Pages
- e9730-e9730
- ISSN
- 1744-4292 (ISSN-L)
- PMC
- PMC7838823
- OpenAlex
- W3124569282
- Cited by
- 149
- References
- 89
- Citations by year
- 2026: 20 · 2025: 27 · 2024: 28 · 2023: 27 · 2022: 26 · 2021: 20
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- other-oa
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 26 d)
- Locations
- Molecular Systems Biology (publishedVersion, other-oa)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, cc-by)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, cc-by)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- RWTH Publications (RWTH Aachen) (submittedVersion, other-oa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by-nc-nd)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by)
- Apollo (cc-by)
- RWTH Publications (RWTH Aachen)
- ETH Zürich Research Collection (cc-by)
- Funders
- Medical Research Council (MC_UU_12022/6)
- Novo Nordisk Fonden (NNF14CC0001)
- Lundbeckfonden (R193‐2015‐243)
- H2020 European Research Council (ERC‐StG 677448)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene Regulatory Network Analysis
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- multi-omics integration, cosmos, phosphoproteomics, transcriptomics, metabolomics, prior knowledge incorporation, signaling networks, gene regulatory networks, metabolic networks, clear cell renal cell carcinoma, therapeutic target, cancer
- MeSH terms
- Carcinoma, Renal Cell, Humans, Kidney Neoplasms, Phosphoproteins, Case-Control Studies, Computational Biology, Gene Expression Profiling, Gene Regulatory Networks, Metabolomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.